Tweenvest Stocks

Allergy Therapeutics plc (AIM: AGY)

Health Care · Pharmaceuticals · GB

£0.05

0.00% today · -44.1% 1Y

Allergy Therapeutics plc (AIM: AGY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $397.96M.

Over the last twelve months the share price has lost 44.1%, trading between 0.05 and 0.12.

Tweenvest scores Allergy Therapeutics plc across four factors: quality 42/100, value 41/100, growth 0/100. Its strongest factor is quality.

AGY price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$397.96M
Revenue (TTM)
$77.11M
P/E
—
EPS
-0.01
Dividend yield
—
Beta (5Y)
0.92
52-week high
£0.12
52-week low
£0.05
Avg volume (3M)
—
Shares outstanding
6.33B
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Chengdu huasun technology group Inc. , LTD.SZSE: 000790$410.99MCN¥4.42-5.56%
Zhejiang East Asia Pharmaceutical Co., Ltd.SHSE: 605177$407.06MCN¥24.26-6.19%
Atea Pharmaceuticals, Inc.NasdaqGS: AVIR$401.83M$5.16+2.89%
Aarti Drugs LimitedBSE: 524348$400.09MRs422.05-1.79%
Turn Therapeutics Inc.NasdaqGM: TTRX$397.07M$11.39-14.55%
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,LtdSHSE: 600671$395.59MCN¥21.79-5.38%
Unichem Laboratories LimitedBSE: 506690$391.59MRs535.50-2.67%
Foresee Pharmaceuticals Co., Ltd.TPEX: 6576$390.70MNT$79.00-1.50%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 4, 2026.